Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antidepressants for people with epilepsy and depression.
Maguire MJ, Marson AG, Nevitt SJ. Maguire MJ, et al. Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682. doi: 10.1002/14651858.CD010682.pub3. Cochrane Database Syst Rev. 2021. PMID: 33860531 Free PMC article.
Vigabatrin add-on therapy for drug-resistant focal epilepsy.
Bresnahan R, Gianatsi M, Maguire MJ, Tudur Smith C, Marson AG. Bresnahan R, et al. Among authors: maguire mj. Cochrane Database Syst Rev. 2020 Jul 30;7(7):CD007302. doi: 10.1002/14651858.CD007302.pub3. Cochrane Database Syst Rev. 2020. PMID: 32730657 Free PMC article.
Antidepressants for people with epilepsy and depression.
Maguire MJ, Weston J, Singh J, Marson AG. Maguire MJ, et al. Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Cochrane Database Syst Rev. 2014. PMID: 25464360 Free PMC article. Updated. Review.
Vigabatrin for refractory partial epilepsy.
Hemming K, Maguire MJ, Hutton JL, Marson AG. Hemming K, et al. Among authors: maguire mj. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD007302. doi: 10.1002/14651858.CD007302.pub2. Cochrane Database Syst Rev. 2013. PMID: 23440814 Updated. Review.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
Vigabatrin for refractory partial epilepsy.
Hemming K, Maguire MJ, Hutton JL, Marson AG. Hemming K, et al. Among authors: maguire mj. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD007302. doi: 10.1002/14651858.CD007302. Cochrane Database Syst Rev. 2008. PMID: 18646179 Updated. Review.
105 results